Hypercalcemia in malignant and inflammatory diseases (Q34677237)

3 August 2017

1 reference

title

Hypercalcemia in malignant and inflammatory diseases (English)

1 reference

3 August 2017

1 reference

Leonard J Deftos

1

1 reference

3 August 2017

publication date

1 March 2002

1 reference

Endocrinology and Metabolism Clinics of North America

3 August 2017

published in

1 reference

3 August 2017

volume

31

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

141-158

1 reference

Retinoid-induced hypercalcemia in a patient with kaposi sarcoma associated with acquired immunodeficiency syndrome

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Hypertensive emergency due to hypercalcemia after acute renal failure secondary to rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Acute rheumatic fever in adults over the age of 45 years: an analysis of 23 patients together with a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Calcium free hemodialysis: experience in the treatment of 33 patients with severe hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Optimising treatment of bone metastases by Aredia(TM) and Zometa(TM).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Hypercalcemia: mechanisms, differential diagnosis, and remedies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Hypercalcemia and systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Parathyroid hormone-related protein in hypercalcemia associated with hematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Ganciclovir-associated hypercalcemia in a renal transplant patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic leukemia and their management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Growth and metabolic disturbances in a patient with total parenteral nutrition: a case of hypercalciuric hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

The humoral hypercalcemia of benignancy. A newly appreciated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Hyperparathyroid and hypoparathyroid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Hypercalciuria and topical calcipotriol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Hypercalcaemia in Greek patients with tuberculosis before the initiation of anti-tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Hypercalcemia and nephrocalcinosis in patients with congenital lactase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Clinical review 122: Parathyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Hypercalcemia in granulomatous disorders: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

Hypercalcemia due to talc granulomatosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900003-2

7 January 2021

10.1016/S0889-8529(01)00003-2

Identifiers

DOI

1 reference

3 August 2017

1 reference